These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31362911)

  • 1. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
    Vahednia E; Shandiz FH; Bagherabad MB; Moezzi A; Afzaljavan F; Tajbakhsh A; Kooshyar MM; Pasdar A
    Clin Breast Cancer; 2019 Oct; 19(5):e563-e577. PubMed ID: 31362911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran.
    Afzaljavan F; Vahednia E; Barati Bagherabad M; Vakili F; Moezzi A; Hosseini A; Homaei Shandiz F; Kooshyar MM; Nassiri M; Pasdar A
    BMC Med Genomics; 2023 Apr; 16(1):72. PubMed ID: 37016353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
    Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
    Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
    Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the IL-10 gene rs1800872 (-592 C>A) polymorphism with breast cancer in a Mexican population.
    Patricia Gallegos-Arreola M; Zúñiga González GM; Figuera LE; Puebla Pérez AM; Delgado Saucedo JI
    J BUON; 2019; 24(6):2369-2376. PubMed ID: 31983108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
    He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
    Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
    Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
    J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
    Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
    Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DNMT1 gene polymorphisms in exons with sporadic infiltrating ductal breast carcinoma among Chinese Han women in the Heilongjiang Province.
    Xiang G; Zhenkun F; Shuang C; Jie Z; Hua Z; Wei J; Da P; Dianjun L
    Clin Breast Cancer; 2010 Oct; 10(5):373-7. PubMed ID: 20920981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of caspase 8 promoter variants and haplotypes with the risk of breast cancer and its molecular profile in an Iranian population: A case-control study.
    Bagherabad MB; Afzaljavan F; Vahednia E; Rivandi M; Vakili F; Sadr SSH; Shandiz FH; Pasdar A
    J Cell Biochem; 2019 Oct; 120(10):16435-16444. PubMed ID: 31257627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
    Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
    Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
    Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
    Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?
    Khabaz MN
    Asian Pac J Cancer Prev; 2014; 15(19):8395-400. PubMed ID: 25339035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
    Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
    Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of hypoxia inducible factor-1α gene polymorphisms with breast cancer in North-West Indians.
    Sharma S; Kapahi R; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR
    Asian Pac J Cancer Prev; 2014; 15(22):9973-8. PubMed ID: 25520138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.